Transient elastography can stratify patients with Child-Pugh A cirrhosis according to risk of early decompensation

被引:9
作者
Dillon, Audrey [1 ]
Galvin, Zita [1 ]
Sultan, Alyshah A. [2 ]
Harman, David [3 ,4 ]
Guha, Indra N. [3 ,4 ]
Stewart, Stephen [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Ctr Liver Dis, Dublin, Ireland
[2] Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England
[3] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England
[4] Univ Nottingham, Nottingham, England
关键词
compensated cirrhosis; fibroscan; prognosis; transient elastography; SIGNIFICANT PORTAL-HYPERTENSION; LIVER STIFFNESS MEASUREMENT; DISEASE; PROGRESSION; PREDICTION; SURVIVAL;
D O I
10.1097/MEG.0000000000001224
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Compensated cirrhosis has a variable prognosis depending on stage. There are currently no straightforward and robust tools in clinical practice to predict decompensation in Child-Pugh A cirrhosis. We set out to determine whether transient elastography (TE) could be used across liver disease aetiologies to determine risk of decompensation. Patients and methods Participants were enrolled at two sites (Dublin and Nottingham) and followed up for a minimum of 2 years. The primary outcome of the study was liver decompensation, defined as the development of overt hepatic encephalopathy or ascites or presentation with bleeding varices. All patients received a TE examination to measure liver stiffness measurement (LSM) and had routine blood measurements taken at the baseline visit and on each subsequent visit. Results In 259 participants, the overall rate of liver-related outcome was 31 per 1000 person-years (95% confidence interval: 19-47 per 1000 person-years). Of the total population, 6 and 11% developed a liver-related outcome within 2 and 4 years of follow-up, respectively. There were no events in the population with a LSM less than 21 kPa. A LSM of more than 35 kPa was associated with a decompensation risk of 39% at 4 years. For each unit increase in the LSM above 20 kPa, the risk of liver-related outcome increased by 6% (hazard ratio = 1.06; 95% confidence interval: 1.04-1.82) after adjusting for age, sex Mayo End Liver Disease Score, cohort source and aetiology. Conclusion The risk of liver decompensation increased with increasing LSM in mixed aetiology compensated cirrhosis. LSM may be used to risk stratify patients, potentially reassure patients with low scores, and select patients with higher scores for experimental therapeutic studies with acceptable timelines. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:1434 / 1440
页数:7
相关论文
共 27 条
[1]   Liver Stiffness Is Influenced by a Standardized Meal in Patients With Chronic Hepatitis C Virus at Different Stages of Fibrotic Evolution [J].
Arena, Umberto ;
Platon, Monica Lupsor ;
Stasi, Cristina ;
Moscarella, Stefania ;
Assarat, Ali ;
Bedogni, Giorgio ;
Piazzolla, Valeria ;
Badea, Radu ;
Laffi, Giacomo ;
Marra, Fabio ;
Mangia, Alessandra ;
Pinzani, Massimo .
HEPATOLOGY, 2013, 58 (01) :65-72
[2]   Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: A prospective study [J].
Augustin, Salvador ;
Millan, Laura ;
Gonzalez, Antonio ;
Martell, Maria ;
Gelabert, Arantzazu ;
Segarra, Antoni ;
Serres, Xavier ;
Esteban, Rafael ;
Genesca, Joan .
JOURNAL OF HEPATOLOGY, 2014, 60 (03) :561-569
[3]   Obesity Is an Independent Risk Factor for Clinical Decompensation in Patients with Cirrhosis [J].
Berzigotti, Annalisa ;
Garcia-Tsao, Guadalupe ;
Bosch, Jaime ;
Grace, Norman D. ;
Burroughs, Andrew K. ;
Morillas, Rosa ;
Escorsell, Angels ;
Carlos Garcia-Pagan, Juan ;
Patch, David ;
Matloff, Daniel S. ;
Groszmann, Roberto J. .
HEPATOLOGY, 2011, 54 (02) :555-561
[4]   The clinical use of HVPG measurements in chronic liver disease [J].
Bosch, Jaime ;
Abraldes, Juan G. ;
Berzigotti, Annalisa ;
Carlos Garcia-Pagan, Juan .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (10) :573-582
[5]   Determination of reliability criteria for liver stiffness evaluation by transient elastography [J].
Boursier, Jerome ;
Zarski, Jean-Pierre ;
de Ledinghen, Victor ;
Rousselet, Marie-Christine ;
Sturm, Nathalie ;
Lebail, Brigitte ;
Fouchard-Hubert, Isabelle ;
Gallois, Yves ;
Oberti, Frederic ;
Bertrais, Sandrine ;
Cales, Paul .
HEPATOLOGY, 2013, 57 (03) :1182-1191
[6]   Hepatocellular carcinoma: clinical frontiers and perspectives [J].
Bruix, Jordi ;
Gores, Gregory J. ;
Mazzaferro, Vincenzo .
GUT, 2014, 63 (05) :844-855
[7]   Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease [J].
Bureau, C. ;
Metivier, S. ;
Peron, J. M. ;
Selves, J. ;
Robic, M. A. ;
Gourraud, P. A. ;
Rouquet, O. ;
Dupuis, E. ;
Alric, L. ;
Vinel, J. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) :1261-1268
[8]   Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations [J].
Castera, Laurent ;
Foucher, Juliette ;
Bernard, Pierre-Henri ;
Carvalho, Francoise ;
Allaix, Daniele ;
Merrouche, Wassil ;
Couzigou, Patrice ;
de Ledinghen, Victor .
HEPATOLOGY, 2010, 51 (03) :828-835
[9]   Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients [J].
D'Amico, G. ;
Pasta, L. ;
Morabito, A. ;
D'Amico, M. ;
Caltagirone, M. ;
Malizia, G. ;
Tine, F. ;
Giannuoli, G. ;
Traina, M. ;
Vizzini, G. ;
Politi, F. ;
Luca, A. ;
Virdone, R. ;
Licata, A. ;
Pagliaro, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1180-1193